Network origin in Peter A. Kresel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter A. Kresel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mylan Specialty LP
 Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Pharmaceuticals: Major | Compliance Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Pharmaceuticals: Major | Human Resources Officer Chief Executive Officer Director of Finance/CFO Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
SBI Investment Co., Ltd.
 SBI Investment Co., Ltd. Investment ManagersFinance SBI Investment Co., Ltd. (SBI Investment) is a venture capital subsidiary of SBI Holdings, Inc. (TK: 8473) headquartered in Tokyo, Japan. The firm was formed in 2005 through the merger of SBI Ventures K.K., Softbank Contents Partners Corp. and Biovision Capital Corp. | Investment Managers | Chief Executive Officer Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| Washington State University | College/University | Graduate Degree Undergraduate Degree | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Washington Biotechnology & Biomedical Association | Chairman Director/Board Member | ||
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OBSEVA SA | Pharmaceuticals: Major | Chief Executive Officer | |
Decoy Biosystems, Inc.
 Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | General Counsel | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
| University of California, Santa Barbara | College/University | Undergraduate Degree | |
| Sonrgy, Inc. | Chief Executive Officer | ||
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Golden Gate University | College/University | Graduate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services University of the Pacific is a nationally ranked university with a long tradition of dedicated teaching, small class sizes, practical experience and vibrant residential life. The breathtaking main campus in Stockton, California is home to seven schools and colleges, with more than 80 majors and programs of study. Pacific also has the McGeorge School of Law in Sacramento and the Arthur A. Dugoni School of Dentistry in San Francisco. Total university enrollment is nearly 7,000, with 3,757 undergraduates in an average class size of 19 and a student/faculty ratio of 14:1. It is located in Stockton, California. | College/University | Undergraduate Degree | |
| The HENLEY College | College/University | Masters Business Admin | |
Century Club of San Diego
 Century Club of San Diego Miscellaneous Commercial ServicesCommercial Services Century Club of San Diego engages in the promotion of golf events to support San Diego community and local youth programs. The company was founded in July 1961 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| SCILEX HOLDING COMPANY | Pharmaceuticals: Other | Chief Executive Officer | |
Calibra Medical LLC
 Calibra Medical LLC Medical SpecialtiesHealth Technology Calibra Medical LLC develops and markets medical devices and technologies in the diabetes sector. Its products include finesse and insulin delivery devices. The company was founded by Daniel Hawkins and Clifton A. Alferness in 2004 and is headquartered in Wayne, PA. | Medical Specialties | Human Resources Officer | |
| HR Executive Forum | Corporate Officer/Principal | ||
Aquavit Pharmaceuticals, Inc.
 Aquavit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquavit Pharmaceuticals, Inc. operates as a healthcare company that discovers, develops, and commercializes therapeutic products. It offers pharmaceuticals, nutraceuticals, and biologics. The company was founded in October 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Society of Human Resource Management | Corporate Officer/Principal | ||
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| CUMBERLAND PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Karlsruhe | College/University | Doctorate Degree | |
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Miscellaneous Commercial Services | Founder |
Statistics
International
| United States | 39 |
| Japan | 5 |
| Germany | 3 |
| Switzerland | 3 |
| Israel | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 2 |
Operational
| Director/Board Member | 79 |
| Corporate Officer/Principal | 35 |
| President | 30 |
| Chief Executive Officer | 24 |
| Director of Finance/CFO | 22 |
Most connected contacts
| Insiders | |
|---|---|
| Yoshitaka Kitao | 49 |
| Brian O'Callaghan | 20 |
| Jaisim Shah | 17 |
| John E. Gebhart | 16 |
| Michael T. Schutzler | 11 |
| David Lowrance | 10 |
| Glen Y. Sato | 10 |
| Edward Danse | 9 |
| Robert Takeuchi | 8 |
| Michelle Carpenter | 8 |
| Takaaki Tobaru | 8 |
| Hien DeYoung | 8 |
| Shiro Mita | 6 |
| Steven C. Tarr | 6 |
| Dewey H. Blocker | 5 |
- Stock Market
- Insiders
- Peter A. Kresel
- Company connections
